Arstasis Scores $25.5M
Redwood City-based Arstasis, a developer of surgical tools for femoral artery access, recently raised $25.5M in a Series E funding round. Names of the investors in the firm were not disclosed. The firm said recently that the funding will go towards working capital and the launch of its AXERA Access Device.
posted on Monday, June 6, 2011 (Link to more information)
Related companies:
Arstasis
Related stories:
> Optovue Scores $10.5M
> Curse Scores $6M
> Skyrider Scores $12M
> Fluidigm Scores $37M
> Tacere Scores Seed Financing
silicontap.com Home